Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice

Diabetic patients suffer from a high rate of cardiovascular events and such risk increases with HbA1c. However, lowering HbA1c does not appear to yield the same benefit on macrovascular endpoints, as observed ...

Source: Cardiovascular Diabetology - August 11, 2016 Category: Cardiology Authors: Angelo Avogaro, Gian Paolo Fadini, Giorgio Sesti, Enzo Bonora and Stefano Del Prato Source Type: research